** Shares of Hims & Hers HIMS.N rise 43% to $40.73 premarket
** Novo Nordisk NOVOb.CO has partnered with the telehealth firm to sell its popular weight loss drug through a bundled offering on HIMS platform
** Starting this week, customers will get access to the offerings of all dose strengths of Wegovy and a membership at a price starting at $599 per month - HIMS
** HIMS says it will continue to offer personalized compounded versions of semaglutide, the active ingredient in Novo's Wegovy
** Earlier this month, HIMS said it plans to sell Eli Lilly's LLY.N Zepbound on its platform
** Up to last close, HIMS up 17.8% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。